Psychedelics and the Mind Course

Lesson 1 • The Modern Research Renaissance

Surveys the resurgence of psychedelic science from the 1990s onward, driven by new institutional support. Students gain awareness of the current research landscape they will study in depth.

Lesson 2 • Core Terminology and Frameworks

Introduces standardised vocabulary and conceptual frameworks used across psychedelic research literature. Ensures students can read primary sources accurately from this point forward.

Lesson 3 • Defining Psychedelics as a Class

Covers the pharmacological criteria distinguishing psychedelics from other psychoactive drugs. Anchors the chapter by establishing precise terminology used throughout the course.

Lesson 4 • The Mid-Century Research Era

Examines the first wave of clinical psychedelic research from the 1940s through the 1970s. Identifies key findings and methodological lessons that inform contemporary studies.

Lesson 1 • Default Mode Network Disruption

Explains how psychedelics suppress default mode network activity and what this means for self-referential thought. Links network changes to therapeutic mechanisms discussed in later chapters.

Lesson 2 • Serotonin System Fundamentals

Reviews serotonergic neurotransmission as the primary target of classical psychedelics. Provides the receptor biology prerequisite for understanding downstream effects.

Lesson 3 • Receptor Pharmacology of Key Compounds

Details binding profiles of psilocybin, DMT, mescaline, LSD, and ketamine. Connects molecular action to the distinct experiential profiles of each substance.

Lesson 4 • Neuroplasticity and Synaptic Changes

Covers psychedelic-induced neuroplasticity, including synaptogenesis and BDNF upregulation. Establishes the biological basis for lasting therapeutic effects.

Lesson 1 • Psilocybin and Psilocin

Profiles the pharmacokinetics, dose ranges, and experiential arc of psilocybin. Serves as the primary clinical compound reference for therapeutic chapters ahead.

Lesson 2 • Ketamine and Dissociatives

Distinguishes dissociative psychedelics from classical serotonergic compounds by mechanism and effect. Prepares students for clinical ketamine content in the therapeutic applications chapter.

Lesson 3 • DMT and Ayahuasca

Covers endogenous DMT, synthetic forms, and the ayahuasca brew's pharmacological synergy. Introduces the concept of MAO inhibition critical for understanding combination preparations.

Lesson 4 • Mescaline and Peyote

Profiles mescaline's phenethylamine structure, slow onset, and long duration. Situates peyote within its indigenous cultural context established in Chapter 1.

Lesson 5 • MDMA as an Entactogen

Profiles MDMA's serotonin-releasing mechanism, empathogenic effects, and clinical trial status. Distinguishes it from classical psychedelics while connecting it to the broader therapeutic landscape.

Lesson 1 • Ego Dissolution and Self-Transcendence

Analyses the psychological construct of ego dissolution and its relationship to therapeutic outcomes. Connects subjective experience to the neurological mechanisms covered in Chapter 2.

Lesson 2 • Emotional and Affective Dimensions

Examines the range of emotional responses, from euphoria to anxiety, during psychedelic states. Prepares students to support participants through difficult emotional material.

Lesson 3 • Perceptual and Sensory Alterations

Describes visual, auditory, and somatic perceptual changes induced by psychedelics. Grounds later clinical assessment skills in an accurate phenomenological baseline.

Lesson 4 • Challenging Experiences and Difficult Trips

Identifies psychological risk factors and common features of difficult psychedelic experiences. Builds the foundation for harm reduction and clinical support skills.

Lesson 1 • Evaluating Trial Quality and Bias

Teaches critical appraisal of psychedelic trial methodology, including blinding challenges and expectancy effects. Equips students to assess new research independently as the field evolves.

Lesson 2 • Ketamine in Clinical Practice

Reviews approved and off-label ketamine protocols for depression and suicidality. Provides a model of a legally available psychedelic-adjacent treatment for clinical comparison.

Lesson 3 • Psilocybin for Depression and Anxiety

Reviews randomised controlled trials of psilocybin for major depression and cancer-related distress. Establishes the strongest current evidence base for psychedelic-assisted therapy.

Lesson 4 • MDMA-Assisted Therapy for PTSD

Examines Phase 2 and Phase 3 trial data for MDMA-assisted psychotherapy in PTSD populations. Highlights the manualised therapy model and its role in outcomes.

Lesson 1 • Participant Screening and Assessment

Covers contraindications, psychological screening tools, and medical history review for psychedelic therapy candidates. Establishes the safety gatekeeping function of the preparation phase.

Lesson 2 • Building Therapeutic Alliance

Examines how trust and rapport between guide and participant predict session outcomes. Connects therapeutic relationship research to the unique demands of psychedelic-assisted work.

Lesson 3 • Intention-Setting and Psychological Readiness

Guides students through facilitating intention-setting conversations and assessing psychological readiness. Prepares participants to engage productively with challenging material during sessions.

Lesson 4 • Physical Environment Design

Details evidence-based principles for designing the physical space of a psychedelic session. Demonstrates how environmental factors directly modulate the quality and safety of the experience.

Lesson 1 • Managing Adverse Events

Covers recognition and response protocols for medical and psychological adverse events during sessions. Ensures students can act decisively to protect participant welfare.

Lesson 2 • Presence and Non-Directive Support

Teaches the skill of attuned, non-intrusive presence as the primary facilitation mode. Connects mindfulness-based attentional skills to effective psychedelic session support.

Lesson 3 • Navigating Difficult Experiences

Provides specific verbal and somatic techniques for supporting participants through fear, grief, or crisis. Builds on the psychological experience framework from Chapter 4.

Lesson 4 • Session Closure and Transition

Guides students through the process of closing a session and transitioning participants to post-session care. Prepares the participant psychologically for the integration work ahead.

Lesson 1 • Integration Modalities and Techniques

Surveys verbal, somatic, creative, and contemplative integration approaches and their respective indications. Equips students to match integration methods to individual participant needs.

Lesson 2 • Behavioural and Lifestyle Change

Connects integration insights to concrete behavioural change planning and habit formation. Bridges the psychological transformation of the session to measurable real-world outcomes.

Lesson 3 • Foundations of Psychedelic Integration

Defines integration, its theoretical basis, and its role in determining long-term therapeutic outcomes. Establishes integration as a distinct clinical skill set requiring dedicated training.

Lesson 4 • Working with Difficult Material

Addresses integration of traumatic content, unresolved grief, and existential challenges surfaced during sessions. Prepares students to hold complex material without pathologising the experience.